A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

NCT05931367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

445

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Osteo Arthritis Knee

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company